title: Late-onset muscle weakness in partial phosphofructokinase deficiency: a unique myopathy with vacuoles, abnormal mitochondria, and absence of the common exon 5/intron 5 junction point mutation.
abstract: Three patients (ages 51, 59, and 79) from two generations of an Ashkenazi Jewish family had partial (33% activity) phosphofructokinase (PFK) deficiency that presented with fixed muscle weakness after the age of 50 years. MR spectroscopy revealed accumulation of phosphomonoesters during exercise. Muscle biopsy showed a vacuolar myopathy with increased autophagic activity and several ragged-red and cytochrome c oxidase-negative fibers. The older patient, age 79 at biopsy, had several necrotic fibers. Electron microscopy revealed subsarcolemmal and intermyofibrillar glycogen accumulation and proliferation of mitochondria with paracrystalline inclusions, probably related to reduced availability of energy due to impaired glycolysis. The common point mutation of exon 5/intron 5 junction seen in Jewish Ashkenazi patients with PFK deficiency was excluded. We conclude that late-onset fixed muscle weakness occurs in partial PFK deficiency and it may represent the end result of continuing episodes of muscle fiber destruction. Partial enzyme deficiency in two successive generations suggests a unique molecular mechanism.
authors.affiliation: Neuromuscular Diseases Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
authors.forename: K
authors.initials: K
authors.lastname: Sivakumar
authors.forename: O
authors.initials: O
authors.lastname: Vasconcelos
authors.forename: L
authors.initials: L
authors.lastname: Goldfarb
authors.forename: M C
authors.initials: MC
authors.lastname: Dalakas
mesh_terms: D000328:Adult; D017668:Age of Onset; D000368:Aged; D000369:Aged, 80 and over; D001483:Base Sequence; D001706:Biopsy; D017931:DNA Primers; D003576:Electron Transport Complex IV / Q000032:analysis; D005060:Europe / Q000208:ethnology; D005091:Exons; D006014:Glycogen Storage Disease Type VII / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D007438:Introns; D007585:Jews; D008875:Middle Aged; D008931:Mitochondria, Muscle / Q000473:pathology; D008969:Molecular Sequence Data; D018656:Muscle Fibers, Fast-Twitch / Q000473:pathology; D018482:Muscle, Skeletal / Q000473:pathology* / Q000503:physiopathology*; D009336:Necrosis; D010375:Pedigree; D010732:Phosphofructokinase-1 / Q000172:deficiency* / Q000235:genetics*; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D014481:United States; D014617:Vacuoles / Q000473:pathology
chemical_list: D017931:DNA Primers; D003576:Electron Transport Complex IV; D010732:Phosphofructokinase-1